Brief: Rapid Micro Biosystems Expects Total Commercial Revenue Of Between $17.0 To $17.2 Mln For 2022
11/01/2023 14:03
Jan 11 (Reuters) - Rapid Micro Biosystems Inc RPID.O :
* RAPID MICRO BIOSYSTEMS ANNOUNCES PRELIMINARY UNAUDITED
FOURTH
QUARTER AND FULL YEAR 2022 REVENUE
* RAPID MICRO BIOSYSTEMS INC - FINISHED 2022 WITH
APPROXIMATELY
$140 MILLION IN CASH AND INVESTMENTS PROVIDING RUNWAY AT LEAST
INTO 2026
* RAPID MICRO BIOSYSTEMS INC - EXPECTS TOTAL COMMERCIAL
REVENUE OF
BETWEEN $17.0 TO $17.2 MILLION FOR FULL YEAR OF 2022
Source text for Eikon: ID:nGNXbrgFPZ
Further company coverage: RPID.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Rapid Micro Biosystems
See all newsRapid Micro Biosystems, Inc. reports results for the quarter ended June 30 - Earnings Summary
Rapid Micro Biosystems Q2 revenue beats; reaffirms 2026 revenue forecast
Rapid Micro Biosystems, Inc. expected to post a loss of 24 cents a share - Earnings Preview
Brief: Rapid Micro Biosystems Announces Pricing Of Up To Around $32 Million Underwritten Offering
Rapid Micro Biosystems Q1 net loss widens, misses estimates